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Abstract
Background:  Mitochondrial DNA (mtDNA) with pathogenic mutations has been found in
patients with cognitive disorders. However, little is known about whether pathogenic mtDNA
mutations and the resultant mitochondrial respiration deficiencies contribute to the expression of
cognitive alterations, such as impairments of learning and memory. To address this point, we used
two groups of trans-mitochondrial mice (mito-mice) with heteroplasmy for wild-type and
pathogenically deleted (Δ) mtDNA; the "low" group carried 50% or less ΔmtDNA, and the "high"
group carried more than 50% ΔmtDNA.
Results: Both groups had normal phenotypes for not only spatial learning, but also memory at
short retention delays, indicating that ΔmtDNA load did not affect learning and temporal memory.
The high group, however, showed severe impairment of memory at long retention delays. In the
visual cortex and dentate gyrus of these mice, we observed mitochondrial respiration deficiencies,
and reduced Ca2+/calmodulin-dependent kinase II-α ( α-CaMKII), a protein important for the
establishment of spatial remote memory.
Conclusion: Our results indicated that normal mitochondrial respiratory function is necessary for
retention and consolidation of memory trace; deficiencies in this function due to high loads of
pathogenically mutated mtDNA are responsible for the preferential impairment of spatial remote
memory.
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Background
Mitochondria are intracellular organelles containing their
own genomes (mtDNA), and playing a crucial role in ATP
production through oxidative phosphorylation. Mamma-
lian mitochondria have multiple copies of mtDNA (103 ~
104 copies/cell) that is replicated and expressed within the
organellar system [1,2]. Mammalian mtDNA encodes 13
polypeptides, which are essential subunits of complexes I,
III, IV, and V for oxidative phosphorylation on the inner
mitochondrial membrane, and 22 tRNAs and 2 rRNAs,
which are necessary for the translation of these 13
polypeptides. The remaining mitochondrial proteins for
oxidative phosphorylation, metabolic enzymes, DNA and
RNA polymerases, and ribosomal proteins are all encoded
by the nuclear genome [1].
The accumulation of pathogenic mtDNAs with large-scale
deletion or point mutations, and the resultant mitochon-
drial respiration deficiencies are associated with a wide
variety of disorders, such as mitochondrial diseases, neu-
rodegenerative diseases, diabetes, and aging [1]. Moreo-
ver, dementia and ataxia are found in patients with
traditional mitochondrial diseases caused by accumula-
tion of mutated mtDNAs, such as MELAS (mitochondrial
encephalopathy, lactic acidosis, and stroke-like episodes),
MERRF (myoclonic epilepsy and ragged red fibers), KSS
(Kearns-Sayre Syndrome), CPEO (chronic progressive
external ophthalmoplegia), and NARP (neurogenic mus-
cle weakness, ataxia, and retinitis pigmentosa) [3-8], and
the same mutated mtDNAs have been identified in
patients with dementia, ataxia, and Alzheimer's disease
[9,10]. Besides, there appears to be a relationship between
mtDNA polymorphisms and cognitive function in
humans [11]. These findings suggest that mtDNAs with
both pathogenic mutations and polymorphisms contrib-
ute to various cognitive disorders, thus leading to demen-
tia, and ataxia. It has been demonstrated that
polymorphisms, at least, in mtDNAs are responsible for
changes in mammalian cognitive function, since the
exchange of mtDNAs between NZB/BINJ and CBA/H
mice affected their learning and exploration processes
[12]. However, there is no direct experimental evidence
that mitochondrial dysfunction induced by pathogenic
mtDNAs results in cognitive disorders, because no proce-
dures are available for the direct introduction of muta-
genized mammalian whole mtDNA into the
mitochondria of living cells, or even into isolated mito-
chondria.
Trans-mitochondrial mice carrying pathogenic mtDNAs
are very useful for addressing whether mitochondrial res-
piration deficiencies induced by the mtDNA mutations
are responsible for cognitive alterations, and, if so, how
they affect brain function. Mito-mice are a type of trans-
mitochondrial mice generated by the direct introduction
of mitochondria carrying ΔmtDNA isolated from cultured
cells into normal pronuclear embryos by a cytoplast
fusion technique [13]. The ΔmtDNA has an expanded
deletion of 4696 bp, from nucleotide position 7,759 in
the tRNALys gene to position 12,454 in the ND5 gene [13],
and is similar to the "common deletion" found in KSS,
and CPEO patients [14]. The great advantages of mito-
mice are that they all share exactly the same nuclear
genomic background (C57BL6/J; B6), and their genetic
variation is restricted to the proportions of introduced
pathogenic ΔmtDNA. Therefore, mito-mice could provide
direct evidence that mitochondrial respiration deficien-
cies induced by mtDNA accumulation are sufficient in
themselves for expression of the clinical phenotypes
observed in patients with mutated mtDNA.
We used these mito-mice to examine the direct relation-
ship between mutated mtDNA and cognitive alteration,
and we succeeded in showing that mutated mtDNA and
the resultant mitochondrial respiration deficiencies were
responsible for impairments of spatial remote memory.
Furthermore, our study demonstrated that mitochondrial
respiration deficiencies gave rise to downregulation of α-
CaMKII, which is important for the establishment of spa-
tial remote memory in the hippocampus and cortex.
These findings suggested that mito-mice with impaired
spatial remote memory would be valuable models for
understanding the molecular mechanisms of cognitive
alteration of mitochondrial origin.
Results
Behavioral and physical features of mito-mice
Mito-mice that are models for mitochondrial diseases
carry both wild-type mtDNA and ΔmtDNA (Figure 1A),
and the proportions of ΔmtDNA differ among individuals
[13]. Not all mito-mice are useful for examining cognitive
alteration, because in mice with severe mitochondrial dis-
ease phenotypes due to high loads of ΔmtDNA (approxi-
mately more than 80%), the abnormal cognitive function
can be overshadowed by other abnormalities in the phe-
notype. In fact, a high load of ΔmtDNA induces locomo-
tor defects in male mito-mice, leading to impaired mating
activity [15]. Furthermore, the proportion of ΔmtDNA in
various tissues of mito-mice increases progressively with
aging, and the mice begin to show the onset of mitochon-
dria-driven diseases other than those manifested cogni-
tively [16]; we therefore had to finish all of our behavioral
analyses before ΔmtDNA accumulated to more than
approximately 80%.
To minimize these problems, we selected mito-mice carry-
ing 21% to 76% ΔmtDNA (n = 30), as determined by
analysis of the mtDNA in their tails at age 4 weeks. The
proportions of ΔmtDNA in other tissues could be deduced
from those in the tail samples without the need to sacrificeMolecular Brain 2008, 1:21 http://www.molecularbrain.com/content/1/1/21
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the mito-mice, because the proportions are very similar
throughout all the tissues of individual mito-mice at age 4
weeks [13,17]. We then classified the mito-mice into two
groups: low (n = 13), carrying 50% or less ΔmtDNA in
their tails, and high (n = 17), carrying more than 50%
(Figure 1B). From our previous studies, we expected that
the mito-mice in the low group would maintain normal
mitochondrial respiration activity, and would thus be
quite healthy during the behavioral analyses, whereas
those in the high group would show slight mitochondrial
respiration abnormalities, and resultant lactic acidosis,
one of the markers for the onset of mitochondrial dis-
eases, at about the time the study ended [13,15]. Since the
genetic variation in the mito-mouse population was lim-
ited to the proportions of exogenously introduced
ΔmtDNA, the low group was used as experimental normal
controls.
Before we focused on cognitive function in the mito-mice,
we examined the locomotor activity and physical per-
formance of the two groups (n = 10 as a low group, and n
= 14 as a high group), because the results of spatial learn-
Genetic characterization and locomotor activity of mito-mice before and after cognitive analyses Figure 1
Genetic characterization and locomotor activity of mito-mice before and after cognitive analyses. (A) Gene map 
of mouse wild-type mtDNA (black) and ΔmtDNA (gray). The white arc in the ΔmtDNA indicates the deleted region expanded 
from the tRNALys to ND5 genes. (B) Two groups of mito-mice were used in the experiment. Mito-mouse population (n = 24) 
was divided into two groups, low (n = 10), carrying 50% or less ΔmtDNA in their tails (at age 4 weeks), and high (n = 14), car-
rying more than 50%. The two groups shared the same nuclear genome background (C57BL/6). (C-F) To examine locomotor 
activity in the low group (black), and high (gray) group, four kinds of traditional behavioral test, the open field test (C) (P = 
0.1638 in before, P = 0.1502 in after), elevated plus maze test (D) (P = 0.9589 in before, P = 0.5703 in after), light-dark transi-
tion test (E) (before: P = 0.8434 in light side, P = 0.1114 in dark side; after: P = 0.1379 in light side, P = 0.8239 in dark side), and 
Porsolt forced-swim test (F) (before: P = 0.3685 in day 1, P = 0.2449 in day 2; after: P = 0.7663 in day 1, P = 0.7735 in day 2), 
were performed before and after cognitive analyses. Results of total distance analyses indicated that there were no differences 
in locomotor activity between the low and high groups. All values are means ± SE.
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ing and memory tests for the study of cognitive function
are easily affected by locomotor and physical abnormali-
ties. We therefore performed an open field test (Figure
1C), elevated plus maze test (Figure 1D and 2A), light-
dark transition test (Figure 1E and 2B), and Porsolt forced-
swim test (Figure 1F and 2C), before and after the cogni-
tive analyses. There were no significant differences
between the low and high groups in terms of locomotor
activity and physical performance, including anxiety-, and
depression-related behaviors, at the two time points (Fig-
ure 1C–1F and 2). From these results, we concluded that
the two groups of mito-mice could be used as an in vivo
Behavioral analyses of mito-mice before and after cognitive analyses Figure 2
Behavioral analyses of mito-mice before and after cognitive analyses. To examine behavioral performances in the 
low group (black), and high (gray) group, three kinds of traditional behavioral tests were performed before and after cognitive 
analyses. (A) Elevated plus maze test. There was no difference in phenotypes of anxiety-related behavior between the low and 
high groups at the two time points (number of total entries: P = 0.6823 in before, P = 0.9775 in after; entries onto open arms: 
P = 0.4360 in before, P = 0.8226 in after; time spent on open arms: P = 0.7157 in before, P = 0.6756 in after). (B) Light-dark 
transition test. There was no difference in phenotypes of anxiety-related behavior between the low and high groups at the two 
time points (time spent in light side: P = 0.9125 in before, P = 0.0625 in after; total number of transitions: P = 0.4083 in before, 
P = 0.4569 in after; first latency to enter light side: P = 0.3812 in before, P = 0.9798 in after). (C) Porsolt forced-swim test. 
There was no difference in phenotypes of depressant-related behaviors between the low and high groups at the two time 
points (before: P = 0.1479 in day 1, P = 0.0526 in day 2; after: P = 0.9900 in day 1, P = 0.3132 in day 2). All values are means ± 
SE.
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model to confirm the direct relationship between mutated
mtDNA and cognitive alteration.
Mito-mice showed abnormalities at long retention delays 
in cognitive analyses
To examine cognitive function in mito-mice (n = 10 as a
low group, and n = 14 as a high group), we performed
Barnes circular maze tests (see Methods), which can reveal
spatial learning and memory ability without the effects by
difference in motor coordination or emotional aspects.
During the course of training (21 trials for 7 days), two
groups of mito-mice learned to locate a single target
among 12 holes. Underneath the target hole was an
escape box containing shredded paper. We measured
three parameters, latency, number of errors, and distance
traveled until they located the target hole. In both groups,
all parameters were progressively reduced with training,
indicating acquisition of spatial learning (Figure 3A).
Spatial learning and memory analyses using Barnes circular maze test in mito-mice Figure 3
Spatial learning and memory analyses using Barnes circular maze test in mito-mice. (A) Training course. Latency 
(P = 0.7381), number of errors (P = 0.5051), and distance traveled (P = 0.7885) to target hole for low (black) and high (gray) 
groups were plotted. (B) Probe tests at 24-h, 7-day, and 36-day after the last training. There was no significant difference in the 
probe test at 24-h (between the target hole and right side hole, P < 0.005 in the low and P < 0.001 in the high groups; between 
the target hole and left side hole, P < 0.05 in the low and P < 0.002 in the high groups) and 7-day retention intervals (between 
the target and right side holes, P < 0.001 in the low and P < 0.001 in the high groups; between the target and left side holes, P 
< 0.05 in the low and P < 0.002 in the high groups). In the probe test at the 36-day retention interval, single and double aster-
isks indicate significant differences between the target and right side holes in the low group (P < 0.02 in the low and P = 0.9804 
in the high groups) and between the target and left side holes in the low group (P < 0.0001 in the low and P = 0.2106 in the high 
groups), respectively. (C) A single retraining after the probe test at the 36-day retention interval. Each score of individual mito-
mice in the low (black) and high (gray) groups were plotted against the proportion of ΔmtDNA in the tails at age 4 weeks. Mice 
52, 64, and 76 carried 52%, 64%, and 76% ΔmtDNA, respectively. Pearson’s product-moment correlation coefficients and the 
associated probabilities are indicated as R and P, respectively. All values are means ± SE.
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Through the training trials, there were no statistical differ-
ences between the two groups in latency, number of
errors, and distance traveled to the target hole (Figure 3A).
These results indicated that a high load of ΔmtDNA was
not required for acquisition of spatial memory, although
we could not rule out the possibility that a load of more
than 80% – the pathogenic threshold for expression of
systemic mitochondrial disease phenotypes – would
induce impairment of spatial learning.
To assess the spatial memory of mito-mice at long reten-
tion delays, we performed probe tests at 24-h, 7-day, and
36-day retention intervals after the last training trial (see
Methods). Since the probe tests were conducted without
an escape box, there was no box for them to escape into
under the target hole. If the mouse had memorized a tar-
get, it would visit the hole where the escape box had pre-
viously been located and spend a long time around it. In
the probe tests at the 24-h and 7-day retention intervals,
which we used to examine temporal memory ability, there
were no statistical differences in the times spent around
the target hole by the two groups (Figure 3B, left and
center panels). However, in the probe test at the 36-day
retention interval, which was used to examine remote
memory ability, the high group spent significantly less
time around the target hole than did the low group (Fig-
ure 3B, right panel). These results indicated that abnor-
malities in spatial remote memory were induced by a high
load of ΔmtDNA.
Phenotypic expression of mitochondrial diseases is regu-
lated by a threshold effect of the mutated mtDNAs: that is,
most phenotypes of mitochondrial disease appear only
when mutated mtDNAs have accumulated to a certain
level [17]. If the ΔmtDNA load were responsible for
abnormalities in spatial remote memory, then only mito-
mice with a high load of ΔmtDNA – beyond a certain
threshold – would be likely not to memorize the target
hole. To confirm this point, we performed a single retrain-
ing of each mito-mouse after the probe test at the 36-day
retention interval, and we measured three parameters dur-
ing the training session: latency, number of errors, and
distance traveled to the target hole with the escape box
under it (see Methods). Increases in the three parameters
were observed in each mito-mouse when the ΔmtDNA
load was more than approximately 60% (Figure 3C). The
results showed that a high load of ΔmtDNA was definitely
responsible for the impairment of spatial remote mem-
ory; they also suggested that the pathological threshold
for expressing the memory impairment phenotype was
approximately 60%.
Accumulation of ΔmtDNA and resultant mitochondrial 
respiration deficiencies in brain tissues of mito-mice
It was not clear whether the impaired spatial remote
memory in the high group was induced by mitochondrial
respiration deficiencies due to high load of ΔmtDNA in
the brain tissues. To address this point, we first estimated
the proportion of ΔmtDNA in brain tissues from the two
groups. We previously reported that ΔmtDNA can accu-
mulate over time in cultured cells and various tissues
because it has replication advantages [13,16]. In consider-
ation of this feature of ΔmtDNA, we selected a high group
of mito-mice in which ΔmtDNA would accumulate only
to less than 80%, even when all the analyses in the study
were finished. The proportion of ΔmtDNA in the skeletal
muscle tissues at age 8.5 months was higher in both
groups than in the tail samples at age 4 weeks. The
increase in the proportion of ΔmtDNA in the skeletal
muscle was 29.2% ± 3.7% in the low group and 22.1% ±
2.7% in the high group (Figure 4A and 4C). The propor-
tion of ΔmtDNA in the brain tissues, however, increased
very little or decreased; at age 8.5 months the proportion
of ΔmtDNA in the brain ranged from 25% to 53% in the
low group (increase compared with tail samples at 4
weeks, 1.6% ± 2.8%) and from 49% to 71% in the high
group (increase compared with tail samples at 4 weeks, -
3.0% ± 1.6%) (Figure 4A and 4C).
It is well known that the enzymatic activity of mitochon-
drial respiratory complexes that contain mtDNA-coded
subunits is reduced by pathogenic mutations in mtDNA.
Reduction in cytochrome c oxidase (Complex IV: COX)
activity is a pathological marker for mitochondrial dis-
eases of mtDNA derivation, because COX contains three
mtDNA-coded subunits, COI, COII, and COIII (see Figure
1A), and the loss of these subunits by mutated mtDNAs
can lead to mitochondrial respiration deficiencies and dis-
ease phenotypes [1]. Since the ΔmtDNA loses 6 tRNA
genes (see Figure 1A), the pathogenicity of the ΔmtDNA is
expressed as lack of all 13 structural gene products which
mtDNA codes, resulting in decreased activity of com-
plexes I, III, IV, and V. We therefore examined the immu-
nohistochemical expression of COI protein, one of the
COX subunits, in order to visualize mitochondrial respi-
ratory function in brain tissues from the two groups. The
COI expression was normal in visual cortical sections
from the low group, because we observed the same level
of COI expression as in normal B6 mice (Figure 4B and
4C). In contrast, visual cortical sections from the high
group showed reduced COI expression; differences in COI
expression level – i.e., very slight, mild, and moderate
stain-loss – were seen in Mice 52, 64, and 76, which car-
ried 55%, 63%, and 71% ΔmtDNA, respectively, in their
brain tissues (Figure 4B and 4C). Then, we performed bio-
chemical analysis for COX activity in brain tissues from
the two groups. There was no significant difference in theMolecular Brain 2008, 1:21 http://www.molecularbrain.com/content/1/1/21
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COX activity between normal B6 mice and low group
mito-mice (Figure 4D). However, we observed a half of
the COX activity in whole brain tissues from the high
group (Figure 4D). From these results, together with the
results of retraining after the last probe test (Figure 3C),
we confirmed that the mitochondrial respiration deficien-
cies due to high load of ΔmtDNA were consistent with the
phenotypic expression of impairments of spatial remote
memory. The three parameters – latency, number of
errors, and distance traveled to the target hole – increased
gradually in the order of Mice 52, 64, and 76 (Figure 4B),
reflecting the hypothesis that phenotypic expression and
severity of impairment of remote memory depended
upon the degree of mitochondrial respiration deficiency.
Expression of α-CaMKII protein in mito-mice
Since it has been suggested that temporal and remote
memory is regulated, respectively, as hippocampal and
cortex-hippocampal tasks, the results of the Barnes circu-
lar maze tests suggested that a high load of ΔmtDNA
affected cortex-hippocampal tasks, rather than hippocam-
pal ones. However, the mechanisms by which mitochon-
drial respiration deficiencies of the brain tissues induced
abnormalities selectively in cortex-hippocampal tasks
were unclear. We therefore compared histological changes
in the hippocampus and visual cortex between the two
groups. No marked histological abnormalities in cell
number and death were seen in either group, with the
exception of the fact that some of the neuronal cells in the
visual cortical sections from high group mice were slightly
smaller than those from low group mice (Figure 5A).
These observations indicated that mitochondrial respira-
tion deficiencies, at least in the high group expressing
impairment of spatial remote memory, did not affect cell
quantity and formation in the visual cortex and hippoc-
ampus, although a very high load of ΔmtDNA (more than
80%) might have induced some histological abnormali-
ties.
α-CaMKII is important for the establishment of remote
memory, including for cortical plasticity and consolida-
tion of memory traces in cortical networks [18]. A part of
α-CaMKII mRNAs is targeted dendritically, then trans-
lated at the site, and then finally matured into constitu-
tively active forms [19]. Since the occurrence of
impairment of spatial remote memory was correlated
with mitochondrial respiration deficiency due to high
load of ΔmtDNA, there was a possibility that mito-mice in
the high group possessed some abnormalities in expres-
sion and/or dendritic distribution of α-CaMKII protein.
To test this, we examined expression of α-CaMKII and
phosphorylated-α-CaMKII (p-α-CaMKII) as the translated
and constitutively active forms, respectively. In visual cor-
tical sections from the low group, both α-CaMKII and p-
α-CaMKII proteins were expressed well and distributed in
dendrites and cytoplasm as well as those in the B6 mouse
(Figure 5B, 5C and 6A). In contrast, we observed a notable
general reduction in both α-CaMKII and p-α-CaMKII pro-
tein expression in the visual cortical sections from the
high group (Figure 5B, 5C and 6A). However, we did not
observed significant difference in the expression levels of
α-CaMKII mRNA among the three groups (Figure 6B),
although the high group mice possessed a slight increase
of the α-CaMKII mRNA level (Figure 6B), probably due to
the compensation of decreased α-CaMKII protein (see Fig-
ure 6A). These results indicated that mitochondrial respi-
ration deficiency affected translation machinery and/or
dendritically-targeting process of α-CaMKII mRNA, rather
than phosphorylation of the protein and transcription of
the mRNA, thus leading to impairment of spatial remote
memory. Moreover, we performed immunohistochemical
analyses to visualize α-CaMKII and p-α-CaMKII proteins
in section of the dentate gyrus (DG), because the DG is
considered to be important in spatial pattern separation
[20], and the specific occurrence of adult neurogenesis
[21]. Consistent with the visual cortical sections, the levels
of expression of both α-CaMKII and p-α-CaMKII proteins
ΔmtDNA load and mitochondrial respiration in brain tissues Figure 4 (see previous page)
ΔmtDNA load and mitochondrial respiration in brain tissues. (A) Accumulation of ΔmtDNA. Because ΔmtDNA is dis-
tributed nearly uniformly throughout all the tissues of a mito-mouse at age 4 weeks, we estimated the increased proportion of 
ΔmtDNA in brain and skeletal muscle tissues after the experiment (at age 8.5 months), based on ΔmtDNA proportions in tail 
samples at age 4 weeks. (B) Relationship between mitochondrial respiratory function and phenotypic expression of impaired 
spatial remote memory. Sections of visual cortex from B6, low group, and high group (Mice 52, 64, and 76) were stained with 
anti-COI antibody and DAPI. Mice 52, 64, and 76 carried 52%, 64%, and 76% ΔmtDNA, respectively, in their tails at age 4 
weeks. Numbers under the sections for Mice 52, 64, and 76 indicate scores in the spatial remote memory experiment shown 
in Figure 3C. (C) Graphic representation of Figures 4A and 4B. In the left graph, bars indicate values obtained from deduction 
of ΔmtDNA proportion in the tail at age 4 weeks from that in brain (black bar) or skeletal muscle (white bar) tissues at age 8.5 
months. In the right graph, quantification of COI positive signals in visual cortex of B6 (white bar), low group (black bar), and 
high group (gray bar) mice were shown. (P=0.5942 in B6 vs low group, P < 0.0001 in B6 vs high group, and P < 0.0001 in low vs 
high groups). (D) Biochemical analysis of COX activity in brain tissues. Whole brain samples from B6 (white bar), low group 
(black bar), and high group (gray bar) were used for the analysis (P=0.3469 in B6 vs low group, P < 0.0005 in B6 vs high group, 
and P < 0.002 low vs high groups). All values are means ± SE. All asterisks indicate significant differences. n.d., not determined.Molecular Brain 2008, 1:21 http://www.molecularbrain.com/content/1/1/21
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in DG sections from the low group were similar to those
in the B6 mouse, whereas these expressions in DG sec-
tions from the high group were notably reduced (Figure
5B and 5C). These immunohistochemical results sug-
gested that a notable reduction in α-CaMKII and p-α-
CaMKII protein production in the visual cortex and DG
may have caused the impairment of spatial remote mem-
ory. The N-methyl-D-aspartate (NMDA) receptor, a major
molecule upstream of α-CaMKII, plays an essential role in
learning and memory in the hippocampus [22], and deg-
radation of NMDA receptor subunits in the hippocampus
contributes to learning and memory defects [23]. We also
performed immunohistochemical analyses with anti-
NMDA receptor 1, but there was no difference in the
expression of NMDA receptor 1 protein between the two
groups (Figure 5D).
Discussion
In healthy mouse models (NZB/BINJ and CBA/H mice) it
has been well documented that mtDNA polymorphisms
are among the genetic candidates for the control of learn-
ing ability [12]. However, there was no direct experimen-
tal evidence as to whether mtDNA with pathogenic
mutations and the resultant mitochondrial respiration
deficiencies are responsible for cognitive alterations. Since
mito-mice share the same nuclear genome background,
and their genetic variations are restricted to the propor-
tions of pathogenic ΔmtDNA – similar to the case with
common deletion types in human diseases [13] – their
use could provide unambiguous evidence that pathologi-
cal phenotypes exclusively observed in mito-mice carrying
high loads of ΔmtDNA are caused by ΔmtDNA-induced
mitochondrial respiration deficiencies. Our experiments
clearly showed that loads of 50% or less ΔmtDNA did not
induce mitochondrial respiration deficiencies in the brain
tissues, and were also not associated with behavioral
abnormalities (Figure 1C–1F, 2, 3, 4B and 4C), whereas
loads of more than 50% were able to induce mitochon-
drial respiration deficiencies, and downregulation of α-
CaMKII protein in brain tissues, leading to impairment of
spatial remote memory (Figure 3B, 4B, 4C, 4D, 5B, 5C
and 6A). We therefore succeeded for the first time in
showing experimental evidence that a high load of patho-
genically mutated mtDNA and the resultant mitochon-
drial respiration deficiencies, in the absence of severe
mitochondrial disease phenotypes, are responsible for the
impairment of spatial remote memory.
It has been considered that remote memory traces are
established by the acquired formation of neuronal circuits
between the hippocampus and cortex and by the resultant
cortical plasticity, whereas learning and temporal memory
are regulated by the existing neuronal circuits in the hip-
pocampus [24]. Frankland et al. [18] have been reported
the possibility that the α-CaMKII modulates the synaptic
events required for the consolidation of memory trace in
cortical networks. Heterozygous mice for a null mutation
of α-CaMKII showed abnormal cortical plasticity and DG
maturation, resulting in impairment of remote memory
[18,25]. These mice showed normal hippocampal plastic-
ity, resulting in no impairment of learning, and temporal
memory [18,25]. Consistent with these reports, expres-
sion levels of α-CaMKII protein were reduced in the corti-
ces and DGs of mito-mice from the high group, and these
mice showed impairment of spatial remote memory (Fig-
ure 3B, 5B and 5C). In contrast, hippocampal plasticity,
which is regulated mainly by existing neuronal circuits in
the hippocampus, is required for initial learning, and tem-
poral memory formation [24]. Genetic disruption experi-
ments in mouse models have indicated that NMDA
receptors are important not only in the formation of neu-
ronal circuits during brain development, but also in the
learning and hippocampus-dependent temporal memory
that use these circuits [23,26]. In mito-mice, irrespective
of the ΔmtDNA load, the level of expression of NMDA
receptor 1 was not altered (Figure 5D); this probably
Histological and immunohistochemical analyses of brain tissues Figure 5 (see previous page)
Histological and immunohistochemical analyses of brain tissues. (A) Histological observations in the hippocampus 
(CA1 region) and visual cortex. Paraffin sections of brain tissues were stained with Kluver-Barrera (KB) stain. (B) Immunohis-
tochemical observations in visual cortex and DG. Frozen sections of brain tissues were stained with anti-α-CaMKII (green) or 
anti-p-α-CaMKII (red) antibody, and with DAPI (blue). a-CaMKII and DAPI signals, or p-α-CaMKII and DAPI signals, were 
respectively merged. (C) Amplified images and quantification of α-CaMKII and p-α-CaMKII in visual cortex and DG areas. A 
part of each image in Figure 5B was representation as amplified images. In the graphic representation, quantification of α-CaM-
KII and p-α-CaMKII positive signals in visual cortex and DG of B6 (white bar), low group (black bar), and high group (gray bar) 
were shown (a-CaMKII in visual cortex: P = 0.5333 in B6 vs low group, P < 0.05 in B6 vs high group, and P < 0.05 in low vs high 
groups; p-a-CaMKII in visual cortex: P = 0.2884 in B6 vs low group, P < 0.02 in B6 vs high group, and P < 0.0001 in low vs high 
groups; a-CaMKII of DG: P = 0.9775 in B6 vs low group, P < 0.02 in B6 vs high group, and P < 0.02 in low vs high groups; p-a-
CaMKII of DG: P = 0.9263 in B6 vs low group, P < 0.05 in B6 vs high group, and P < 0.02 in low vs high groups). Values are the 
means ± SE. Asterisks indicate significant differences. (D) Immunohistochemical observations in the hippocampus (CA1 region). 
Paraffin sections of brain tissues from B6, low group, and high group mice were stained with anti-NMDA receptor 1 antibody. 
All scale bars, 50 μm.Molecular Brain 2008, 1:21 http://www.molecularbrain.com/content/1/1/21
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explains why all the mice had normal spatial learning and
temporal memory (Figure 3A and 3B). Therefore, the
occurrence of mito-mouse phenotypes in which spatial
remote memory was impaired but spatial learning and
temporal memory were not indicated that mitochondrial
respiratory function plays an integral role in the forma-
tion of acquired neuronal circuits between the cortex and
hippocampus, and/or neuronal plasticity in the cortex,
rather than in the use of existent neuronal circuits in the
hippocampus.
The pathophysiological mechanisms of mitochondria-
related impairment of spatial remote memory can be con-
sidered in the following way. When more than 60%
ΔmtDNA accumulates in the brain, mitochondrial respi-
ration deficiencies are induced. Reduction and depletion
of the mitochondrial energy supply would affect the proc-
esses of translation and/or targeting of α-CaMKII mRNA.
The reduced α-CaMKII protein would cause impairment
of spatial remote memory. There are several possible rea-
sons why α-CaMKII protein was downregulated in the
brain tissues of mito-mice with high ΔmtDNA loads. The
Quantification of α-CaMKII protein and mRNA in visual cortex Figure 6
Quantification of α-CaMKII protein and mRNA in visual cortex. (A) Quantification of α-CaMKII protein in the visual 
cortex by Western blotting analysis. Extracted protein of the visual cortex from B6, low group, and high group were blotted 
with an anti-α-CaMKII antibody. Bars indicate values of α-CaMKII protein expression in the visual cortex from the B6 (white 
bar), low group (black bar), and high group (gray bar). In the high group, remarkable downregulation of α-CaMKII proteins (P = 
0.5148 B6 vs low group, P < 0.005 B6 vs high group, P < 0.005 low group vs high group) was observed. The β-actin was used as 
a loading control in the Western blotting. Values are the means ± SE. Asterisks indicate significant differences. (B) Quantifica-
tion of α-CaMKII mRNA in the visual cortex. Total mRNAs were extracted from frozen samples of the visual cortex from B6, 
low group and high group, and cDNAs were obtained by a reverse transcription method. Relative expression levels of α-CaM-
KII mRNA were determined by a real-time monitoring PCR technique. Bars indicate values of relative expression levels of α-
CaMKII mRNA in the B6 (white bar), low group (black bar), and high group (gray bar). The β-actin was used as a loading con-
trol in the real-time monitoring PCR technique. There was no significant difference among the three groups (P = 0.9972 B6 vs 
low group, P = 0.6214 B6 vs high group, P = 0.6238 low group vs high group). Values are means ± SE.
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first is that mitochondrial energy supply is necessary for
the dendritically targeted processes of α-CaMKII mRNA. It
is well known that the mRNAs of α-CaMKII are targeted to
dendrites, and that additional transcription and matura-
tion events occur after this targeting [19]. Many proteins,
including cytoskeletal components and ion-motive
ATPases, that are critical for the dendritically targeted
processes of α-CaMKII mRNA require ATP [27,28]. Thus,
one possible reason is that mitochondrial respiration defi-
ciencies could induce abnormalities in the localization of
α-CaMKII mRNAs, and the resultant downregulation of
its protein form. This possibility was supported by normal
level of α-CaMKII mRNA in the high group (Figure 6B).
However, the reduction of α-CaMKII protein in high
group brain did not always occur specially in dendrites
(Figure 5C). The second possibility is that exogenous sig-
nals derived from other tissues carrying ΔmtDNA at high
levels contribute to the reduction of α-CaMKII protein
production in the brain tissues of the mito-mice. Taking
this study together with our previous one [16], most tis-
sues in the high group were allowed to accumulate
ΔmtDNA with aging, and these tissues fell into mitochon-
drial respiration deficiency, even though the proportion
of ΔmtDNA in the brain tissues did not increase (Figure
4A and 4C). Systemic mitochondrial respiration deficien-
cies give rise to lactic acidosis, which is one of the diagnos-
tic markers of mitochondrial diseases [1], and the lactate
can bind Ca2+ [29]. The onset of lactic acidosis, therefore,
could disturb calcium homeostasis and signaling in nerve
cells, probably leading to the general reduction of α-CaM-
KII protein (Figure 5C), although all vital functions that
occur via calcium signaling should in fact be affected by
the lactic acidosis.
In the brain tissues of the mito-mice, a ΔmtDNA load of
more than 60% could induce mitochondrial respiration
deficiencies (Figure 4B). The threshold ΔmtDNA load
leading to mitochondrial respiration deficiencies in the
brain tissues was clearly lower than that in other tissues; a
ΔmtDNA load of more than approximately 80% is needed
for the occurrence of mitochondrial respiration deficien-
cies in skeletal and cardiac muscle, and in renal, pancre-
atic, and testicular tissues [13,15,17,30]. Considering that
the brain is a high-energy-demand tissue [1], the lower
load of ΔmtDNA was sufficient to induce mitochondrial
respiration deficiencies in the brain tissues. In addition, it
has been reported that a calcium-regulated signal pathway
controls mitochondrial biogenesis, since transgenic mice
with overexpression of CaMKIV in their skeletal muscles
show enhanced mitochondrial biogenesis, including
enhanced mtDNA replication, mitochondrial respiration,
and fatty acid metabolism [31]. If mitochondrial biogen-
esis in the brain is also controlled by a calcium-regulated
signal pathway, then a reduction in CaMKII production
might participate in mitochondrial respiration deficien-
cies in brain tissues. The potential involvement of CaMKII
in mitochondrial respiration requires further investiga-
tion. Moreover, the brain tissues of mito-mice showed lit-
tle or negative accumulation of ΔmtDNA without
neuronal cell death (Figure 4A and 4C) [16], even when
the proportions of ΔmtDNA in other tissues increased
(Figure 4A and 4C). This phenomenon suggested that the
replication frequency of mtDNA molecules differs in each
tissue, and that the frequency in the brain is the lowest
among various tissues [16]. In human brains, however, it
has been reported that deleted mtDNAs accumulate clon-
ally in single cells during aging [32]. Therefore, it remains
to be answered why the mouse brain was sensitive to a
low load of ΔmtDNA, more than 60%, and why ΔmtDNA
did not accumulate in the mouse brain.
The disease phenotypes caused by pathogenic mtDNAs
differ among the types of mutation. For instance, muta-
tions in particular tRNA genes are responsible for MELAS,
MERRF, and cardiomyopathy, whereas ones in structural
genes induce Leigh syndrome, and Leber's disease [33].
We previously generated a novel mouse model (mito-
mouse COI) carrying homoplasmic mtDNA with a path-
ogenic point mutation in the COI  gene (COImut-
mtDNA) [34]. The mito-mice COI looked healthy
throughout life, because of the lower pathogenicity of
COImut-mtDNA compared with that of ΔmtDNA, but
they showed slight mitochondrial respiration deficiencies
in all tissues examined [34]. We have obtained prelimi-
nary data that mito-mice COI do not have impairment of
spatial remote memory, but they have other cognitive
function phenotypes (unpublished data). These findings
suggest that the occurrence of clinical phenotypes in cog-
nitive function also differs among different types of muta-
tion, and is directly regulated by the intensity of the
pathology of mitochondrial respiration. Experimental
support for this possibility will require further investiga-
tion.
Conclusion
In summary, our results suggested the importance of
mitochondrial respiration for maintaining the plasticity
critical for establishment of spatial remote memory. In
mitochondrial respiration deficiencies, nerve cells that
participate in cortical and hippocampal plasticity are una-
ble to produce α-CaMKII protein; this preferentially leads
to impairment of spatial remote memory. The mito-
mouse is a very valuable model system for understanding
the fundamental roles of mitochondrial respiratory func-
tion in retention and consolidation of memory trace,
because this mouse is the only mammalian model with
impairment of spatial remote memory caused by mito-
chondrial respiration deficiency. On the basis of our find-
ings, we suggest that some cases of human memory defect
are caused by high loads of mutated mtDNA and theMolecular Brain 2008, 1:21 http://www.molecularbrain.com/content/1/1/21
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resultant mitochondrial respiration deficiencies. We also
suggest that improving mitochondrial respiration might
be an effective strategy for treating memory disorders,
although there are biological differences between such
disorders in humans and mice.
Methods
Mice
Thirty male mito-mice carrying various proportions of
ΔmtDNA were used for this study. The proportion of
ΔmtDNA in mito-mice was deduced from tail DNA sam-
ples, because it was very similar in all the tissues of the
same individual mouse [13,17]. Age-matched male B6
mice (n = 6) were used as normal controls in histological,
immunohistochemical, biochemical, Western blotting,
and real-time monitoring PCR analyses.
Estimation of ΔmtDNA proportions by real-time 
monitoring PCR
Real-time monitoring PCR was used to estimate the pro-
portions of ΔmtDNA in tails mito-mice at age 4 weeks and
in brain and skeletal muscle tissues of mito-mice after all
behavioral analyses (at age 8.5 months). It was performed
with a TaqMan PCR reagent kit and an ABI PRISM
7900HT sequence detection system (Applied Biosystems,
Foster City, CA). To estimate the absolute copy number of
wild-type mtDNA and ΔmtDNA, we used the standard
curve method. The standard curve for the assay was calcu-
lated using a series of 10-fold dilution of titrated synthetic
standard DNA. Each measurement was repeated three
times, and the proportions of ΔmtDNA and total mtDNA
were calculated. The primer set specific for ΔmtDNA was
TTTCACTATGAAGCTAAGAGCGTTAACCT and GGT-
GGAATCGGACCAGTAGGA. The reporter dye 6-carboxy-
fluorescein (FAM)-labeled TaqMan minorgroove-binder
probe specific for ΔmtDNA was AACTGGTGTATGGA-
GATTT. The primer set specific for wild-type mtDNA was
AACCTGGCACTGAGTCACCA and GGGTCTGAGTG-
TATATATCATGAAGAGAAT. The reporter dye FAM and
the quencher dye 6-carboxy-tetramethyl-rhodamine
(TAMRA)-labeled probe was TCTGTAGCCCTTTTTGTCA-
CATGATC.
Behavioral analysis
Animals and experimental design
Mice were housed four per cage in a room with a 12-hr
light-dark cycle (lights on at 7:00 a.m.) with access to food
and water ad libitum. Behavioral testing was performed
between 9:00 a.m. and 6:30 p.m. After the tests, the appa-
ratus were cleaned with super hypochlorous water to pre-
vent a bias due to olfactory cues. All behavioral tests were
conducted in a manner similar to those described previ-
ously [35], and performed with male mice between 5 and
8 months after birth. All behavioral testing procedures
were approved by the Animal Care and Use Committee of
Kyoto University Graduate School of Medicine.
Open field test
Open field test was performed with male mice before (at
age 5 months) and after (at age 8 months) cognitive anal-
yses, respectively. Each mouse was placed in the center of
the open field apparatus (40 × 40 × 30 cm; Accuscan
Instruments, Columbus, OH). Total distance traveled (in
cm), and number of fecal boli were recorded. Data were
collected for 120 min.
Elevated plus maze test
Elevated plus maze test was performed with male mice
before (at age 5 months) and after (at age 8 months) cog-
nitive analyses, respectively. The elevated plus maze
(O'Hara & Co., Tokyo, Japan) consisted of two open arms
(25 × 5 cm) and two enclosed arms of the same size, with
15-cm high transparent walls. The arms and central square
were made of white plastic plates, and were elevated to a
height of 55 cm above the floor. To minimize the likeli-
hood of animals falling from the apparatus, 3-mm high
plastic ledges were provided for the open arms. Arms of
the same type were arranged at opposite sides to each
other. Each mouse was placed in the central square of the
maze (5 × 5 cm), facing one of the closed arms. Mouse
behavior was recorded during a 10-min test period. The
number of entries onto, and the time spent on open and
enclosed arms, were recorded. For data analysis, we used
the following four measures: total distance traveled (cm),
the number of total entries, the percentage of entries onto
the open arms, and the time spent on the open arms (s).
Data acquisition and analysis were performed automati-
cally using Image EP software (see 'Image analyses').
Light-dark transition test
Light-dark transition test was performed with male mice
before (at age 5 months) and after (at age 8 months) cog-
nitive analyses, respectively. The apparatus used for the
light/dark transition test consisted of a cage (21 × 42 × 25
cm) divided into two sections of equal size by a partition
containing a door (O'Hara & Co., Tokyo, Japan). One
chamber was brightly illuminated (390 lux), whereas the
other chamber was dark (2 lux). Mice were placed into the
dark side, and allowed to move freely between the two
chambers with the door open for 10 min. Total distance
traveled, time spent in each side, total number of transi-
tions between chambers, and first latency to enter the
light side were recorded automatically.
Porsolt forced-swim test
Porsolt forced-swim test was performed with male mice
before (at age 5 months) and after (at age 8 months) cog-
nitive analyses, respectively. The apparatus consisted of
four plastic cylinders (20 cm height × 10 cm diameter).Molecular Brain 2008, 1:21 http://www.molecularbrain.com/content/1/1/21
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The cylinders were filled with water (23°C) up to a height
of 7.5 cm. Mice were placed into the cylinders, and their
behavior recorded over a 10-min test period for 2 days.
Data acquisition and analysis were performed automati-
cally, using Image PS software (see 'Image analyses'). The
total distance traveled, and the percentage of immobility
were measured by Image OF software (see 'Image analy-
ses') using stored image files.
Barnes circular maze test
The Barnes circular maze test was conducted on "dry
land", a white circular surface, 1.0 m in diameter, with 12
holes equally spaced around the perimeter (O'Hara & Co.,
Tokyo, Japan). The circular open field was elevated 75 cm
from the floor, and evenly illuminated by overhead fluo-
rescent white room lighting (1000 lux). A black Plexiglas
escape box (17 × 13 × 7 cm) containing shredded paper
was located under one of the holes. The hole above the
escape box represented the target, analogous to the hid-
den platform in the Morris task. The location of the target
was consistent for a given mouse, but was randomized
across mice. The maze was rotated daily, with the spatial
location of the target unchanged with respect to the distal
visual room cues, to prevent a bias based on olfactory or
proximal cues within the maze. Three trials per day were
conducted for 7 successive days. On day 8, a probe test
was conducted without the escape box, to confirm that
this spatial task was acquired based on navigation using
distal environment room cues. Three trials were con-
ducted immediately after the probe test, and 7 and 36
days later additional probe tests were conducted again. A
single retraining was conducted 7 days later after the
probe test at the 36-day retention interval. Latency,
number of errors, and distance traveled until they located
to the target hole, and time spent around each hole were
recorded by Image BM software (see 'Image analyses').
Image analyses
The applications used for the behavioral studies (Image
EP, Image PS, Image OF, and Image BM) were based on
the public domain NIH Image program (developed at the
U.S. National Institutes of Health, and available on the
Internet at http://rsb.info.nih.gov/nih-image/ and ImageJ
program http://rsb.info.nih.gov/ij/, which were modified
for each test by Tsuyoshi Miyakawa (available through
O'Hara & Co., Tokyo, Japan).
Histological and immunohistochemical procedures
Brain samples fixed with 4% paraformaldehyde were used
for immunohistochemistry with anti-α-CaMKII (BD Bio-
sciences, San Jose, CA), anti-p-α-CaMKII (Promega, Mad-
ison, WI), and anti-COI (Molecular Probes, Inc., Eugene,
OR) antibodies. Frozen sections of the fixed samples were
reacted to the primary antibodies, and then visualized
with secondary antibodies Alexa Fluor 488 (for anti-α-
CaMKII and anti-COI antibodies) and 594 (for anti-p-α-
CaMKII) conjugated goat anti-IgGs (Molecular Probes,
Inc., Eugene, OR). The sections were stained with DAPI to
visualize all nuclei. For Kluver-Barrera (KB) staining and
immunohistochemistry with an anti-NMDA receptor 1
antibody, brain tissues fixed in 4% formaldehyde were
used. Paraffin sections (10 μm thick) of the fixed samples
were stained with KB method. The sections were also
reacted to an anti-NMDA receptor 1 antibody (Acris Anti-
bodies GmbH, Hiddenhausen, Germany) followed by a
secondary antibody, biotinylated goat anti-IgGs, and
VECTASTAIN ABC kit (Vector Laboratories, Inc., Burlin-
game, CA). The sections stained with anti-NMDA receptor
1 antibody were counterstained with hematoxylin to visu-
alize all nuclei. Quantification of COI-, α-CaMKII-, and p-
α-CaMKII-positive signals were performed by ImageJ pro-
gram http://rsb.info.nih.gov/ij/.
Analysis of complex IV (COX) activity
Estimation of COX activity was carried out by examining
the rate of cyanide-sensitive oxidation of reduced cyto-
chrome c [36] with modifications. Biochemical analysis
was based on the procedure described before [37].
Western blotting
To detect α-CaMKII protein, frozen visual cortex regions
were lysed on ice in 2% SDS (Wako, Osaka, Japan), 50
mM Tris-HCl (pH 6.8), 10% Glycerol (Wako, Osaka,
Japan), and 5% 2-Mercaptoethanol (Wako, Osaka,
Japan). After centrifugation, the supernatant was used as a
sample. Proteins were resolved by SDS-PAGE under
reducing conditions. The resolved proteins were trans-
ferred electrophoretically to a nitrocellulose membrane
(GE Healthcare Bio-Sciences KK, Tokyo, Japan). After
incubation with phosphate-buffered saline (PBS, pH 7.4)
in 1% Bovine serum albumin (BSA; Sigma-Aldrich, St.
Louis, MO) for at least 1 h at room temperature, the mem-
brane was incubated with an anti-α-CaMKII antibody (BD
Biosciences, San Jose, CA) for 1 h at room temperature,
washed extensively with PBS in 0.1% Tween-20 (ICN Bio-
medicals Inc., Aurora, OH), and then incubated with
biotinylated goat anti-IgGs, and VECTASTAIN ABC kit
(Vector Laboratories, Inc., Burlingame, CA). Proteins were
detected using Immunostaining HRP-1000 (Konica
Minolta, Tokyo, Japan). For loading controls, incubated
with a monoclonal anti-β-actin antibody (Sigma-Aldrich,
St. Louis, MO) followed by incubation with a horseradish
peroxidase-conjugated goat anti-mouse IgG. Each meas-
urement was repeated three times, and the expression of
α-CaMKII protein was quantified. Quantification of α-
CaMKII protein was performed by ImageJ program http:/
/rsb.info.nih.gov/ij/.Molecular Brain 2008, 1:21 http://www.molecularbrain.com/content/1/1/21
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Real-time monitoring RT-PCR
Total RNA was extracted by ISOGEN (Nippon Gene,
Tokyo, Japan) from frozen organs in mouse brain visual
cortex. RNA samples were subjected to DNase I treatment
(Invitrogen, Carlsbad, CA) to eliminate DNA contami-
nants, and reverse transcribed using Oligo (dT)12–18
Primer (Invitrogen, Carlsbad, CA), 10 mM dNTP Mix
(Invitrogen, Carlsbad, CA), 0.1 M DTT (Invitrogen,
Carlsbad, CA), RNase Out Recombinant Ribonuclease
Inhibiter (Invitrogen, Carlsbad, CA), and SuperScript II
RNase H-Reverse Transcriptase (Invitrogen, Carlsbad,
CA). cDNA samples were subjected to RNaseH treatment
(Invitrogen, Carlsbad, CA). Real-time monitoring PCR
was performed with SYBR Green PCR Master Mix and an
ABI PRISM 7900HT sequence detection system (Applied
Biosystems, Foster City, CA). The primer set specific for α-
CaMKII was GTCGGAATTCCATCCTCACCACTATGCTG
and AAGGATCCATCGATGAAAGTCCAGGCCC. Quanti-
tatve-PCR for β-actin mRNA was also performed on the
same samples, to correct for any residual differences in the
initial level of RNA in the specimens. Results were then
normalized using β-actin mRNA levels in the same sam-
ples. The primer set specific for β-actin was GGTCATCAC-
TATTGGCAACGAG and GTCAGCAATGCCTGGGTACA.
Each measurement was repeated three times, and the
expression levels of α-CaMKII mRNA were calculated.
Statistical analyses
Statistical analyses were performed by using a commer-
cially available software package (STATVIEW, SAS Insti-
tute, Cary, NC) or the data analyses add-in for Microsoft
Excel. One-way ANOVA followed by Student's t-tests were
used for Figures 1D, 1E, 2A, 2B, 4C, 4D, 5C, 6A, and 6B.
Two-way repeated-measures ANOVA followed by the two-
tailed Student's t-tests were used for Figures 1C, 1F, 2C,
and 3A. Paired comparisons t-tests were used for Figure
3B. The relationship between latency, number of errors, or
distance and proportion of ΔmtDNA in tails followed by
calculating the Pearson's correlation coefficient were used
for Figure 3C. Values with P < 0.05 were considered signif-
icant.
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